Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Sandy Paton
Authored Items
Cost-Sharing Has Negative Effects on Biologics
Sandy Paton
Web Exclusives
in
Conference Highlights AMCP
Clinical Journals Valuable Source for Formulary Decisions
Sandy Paton
Web Exclusives
in
Conference Highlights AMCP
Disease Management and Wellness Programs for Employees Work
Sandy Paton
Web Exclusives
in
Conference Highlights AMCP
Medication Therapy Management Project ? The Latest Information for Managed Care Pharmacy
Sandy Paton
May 2008, Vol 1, No 4
in
Conference Highlights AMCP
Responding to FDA Alerts: How to Reduce Risks and Liability
Sandy Paton
May 2008, Vol 1, No 4
in
Conference Highlights AMCP
Last modified: July 21, 2010
